M
Power Law company profile
MorphoSys
Biotech & Life Sciences · Planegg, Germany · Founded 1992 · IPO 2018 Unicorn
Valuation
$2.72B
Market cap · 2026
Revenue
$262M
Latest reported FY
Global footprint
Where MorphoSys has talent and traffic
Web traffic by country
450
monthly visits
across markets
across markets
🇺🇸 United States66.7%
🏳️ Georgia22.2%
Patent intelligence
$322M patent portfolio · 149 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$322M
11.8% of market cap · 6.3× smaller than top peer Ablynx ($2B)
149 active patent families
Where MorphoSys innovates
Molecular biologyOncologyBiochemistryBioinformaticsPharmaceutical medicine
Above peer median on Strategic
Quality vs same-sector peers
MorphoSys on the five Patsnap quality dimensions
MorphoSys in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where MorphoSys concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across MorphoSys and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee MorphoSys on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.